Disease & disorder
corticobasal degeneration disorder
MONDO:0022308
A progressive neurodegenerative condition affecting the cerebral cortex and basal ganglia. The disorder is characterized by varying degrees of cognitive and motor impairment.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
19 showntDCS as Treatment for Motor FunctionNCT07291687 · 2025-10-30
RECRUITINGNeurodegenerative Diseases Progression Markers (MARKERS-NDD)NCT06596746 · 2024-09-09
RECRUITINGThe Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersNCT06174948 · 2024-03-25
RECRUITINGNYSCF Scientific Discovery BiobankNCT06203106 · 2022-11-10
RECRUITINGThe Swedish BioFINDER 2 StudyNCT03174938 · 2017-05-15
RECRUITINGModifiable Variables in Parkinsonism (MVP)NCT02194816 · 2012-09-01
RECRUITINGUnstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian DisordersNCT05638477 · 2022-12-01
UNKNOWNCommunity Outreach for Palliative Engagement -- Parkinson DiseaseNCT05222386 · 2022-04-26
ACTIVE_NOT_RECRUITINGNeurological Soft Signs in Neurodegenerative DementiasNCT06354933 · 2022-04-01
COMPLETEDSociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyNCT06209515 · 2022-01-01
ACTIVE_NOT_RECRUITINGOptimization of Morphomer-based Alpha-synuclein PET TracersNCT05067192 · 2021-07-15
COMPLETEDComplex Eye Movements in Parkinson's Disease and Related Movement DisordersNCT04925622 · 2021-01-04
COMPLETEDAutologous Stem/Stromal Cells in Neurological Disorders and DiseaseNCT03297177 · 2020-01-01
UNKNOWNMisfolded Proteins in the Skin of People With Parkinson's Disease and Other ParkinsonismNCT04518059 · 2019-03-12
COMPLETEDBrain Network Activation in Patients With Movement DisordersNCT03269201 · 2019-03-01
UNKNOWNMore Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseNCT03076671 · 2017-03-01
COMPLETEDEarly-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural NetworksNCT03153371 · 2016-04-04
COMPLETEDGait Analysis in Neurological DiseaseNCT02994719 · 2016-03-01
ACTIVE_NOT_RECRUITINGDefining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.NCT02132052 · 2013-11-01
COMPLETEDDrugs being studied
Research locations
AuroraColorado, United States2BostonMassachusetts, United States1ClevelandOhio, United States1LondonUnited Kingdom1Los AngelesCalifornia, United States1MalmöSweden1New YorkNew York, United States1PhoenixArizona, United States1Ramat GanIsrael1RochesterNew York, United States1San FranciscoCalifornia, United States1TorontoOntario, Canada1
Leading sponsors
Skane University Hospital2University of Colorado, Denver2Bastyr University1Baycrest1Beth Israel Deaconess Medical Center1Casa di Cura San Raffaele Cassino1Conor Fearon1Kuopio University Hospital1New York Stem Cell Foundation Research Institute1Queen Mary University of London1Regeneris Medical1Saccadous, Inc.1Sheba Medical Center1University Hospitals Cleveland Medical Center1University of California, Los Angeles1
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.